Global Overview of COVID-19 Published. BALSA Report.

Global Overview of COVID-19 Testing. The Development of a Core Curriculum.

The Virus Project commissioned a research report by BALSA a consulting enterprise operating from the Washington University in St. Louis.

The report provides an overview of the scientific, regulatory and market issues for the COVID-19 testing in the United States. It is an exceptional resource for understanding the COVID testing marketplace.

The report provides an over view of this new market that largely did not exist in January 2020 but could reach $20 billion in revenues in 2021. It would be the fastest market growth for a dead start in history.

Authors of the report produced a growth model on the potential size of the market and the various market segments.  It includes an analysis of the impact on public stocks by COVID-19 during spring of 2020.

The report offers a summary of Core Testing Technologies: Molecular (PCR) tests and Serology  IgM, IgA, IgG with a discussion of types of immunoassays for antibody detection.

It also identifies various miscellaneous testing technology that have emerged including: Isothermal nucleic acid amplification; CT imaging; CRISPR; Machine Learning; Rapid Antigen; Neutralization Assays; NGS and Monitoring host immune response

The reports provides insight on the complimentary products and supply chain with summaries of  Molecular Tests, Swabs and Serology Tests.

Other key elements of the report on key issues related to commercialization and on a regulatory analysis covers the FDA with a discussion of validation FDA notification and issues after EUA submission.

Lastly the report discusses health insurance regulation and coverage, offering a summary of how the US government and the rules under which the health providers are expected to operate.

This full report and appendix span 50 page with 268 references. It is an ideal primer for anyone serious about understanding the COVID-19 Testing Marketplace.

  • Outline
  • Market Overview
    • Market Value
      • COVID-19 Growth Model
      • Market Value Segmentation
    • Current Investments
    • Stocks Impacted by COVID-19
  • Core Testing Technologies
    • Molecular
    • Serology
      • IgM, IgA, IgG
      • Types of immunoassays for antibody detection
  • Miscellaneous testing technology
    • Isothermal nucleic acid amplification
    • CT imaging
    • CRISPR
    • Machine Learning
    • Rapid Antigen
    • Neutralization Assays
    • NGS
    • Monitor host immune response
  • Complimentary Products and Supply Chain
    • Molecular Tests
    • Swabs
    • Serology Tests
  • Commercialization
  • Regulatory
    • Validation
    • FDA notification
    • After EUA submission
  • Health insurance regulation and coverage
  • Opportunities and Challenges
  • Recommendations

ABOUT: The BALSA Group was the first consulting organization of its kind, dedicated to preparing PhD students and postdocs for careers beyond academia. It has since inspired additional consulting groups in other cities across the United States such as MiLEAD in Ann Arbor, Michigan and Forth River Solutions in Pittsburgh, Pennsylvania.

BALSA has been featured by Nature and Science for its innovative business model and success. In addition, BALSA published a 2013 Nature Biotechnology  piece describing the gaps in academic training that motivated its creation and its ongoing efforts to change university culture surrounding non-academic careers for PhDs. The article was the journal’s most read paper that year, has been cited 39 times, and has an Altmetric score ranking in the 99th  percentile of similarly aged articles for all journals.

Virus Project Members can download the report and the deck HERE

Comments are closed.